<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="112">
  <stage>Registered</stage>
  <submitdate>2/08/2005</submitdate>
  <approvaldate>12/08/2005</approvaldate>
  <actrnumber>ACTRN12605000136606</actrnumber>
  <trial_identification>
    <studytitle>A randomised clinical trial of physical activity for the treatment of older adults with mild cognitive impairment</studytitle>
    <scientifictitle>A randomised clinical trial to evaluate the effect of physical activity on cognition and quality of life in the conditons subjective memory complaints, mild cognitive impairment and Alzheimer's disease.</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Mild Cognitive Impairment
</healthcondition>
    <healthcondition>Subjective Memory Complaints</healthcondition>
    <healthcondition>Alzheimer's Disease</healthcondition>
    <conditioncode>
      <conditioncode1>Neurological</conditioncode1>
      <conditioncode2>Dementias</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Neurological</conditioncode1>
      <conditioncode2>Neurodegenerative diseases</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Neurological</conditioncode1>
      <conditioncode2>Alzheimer's disease</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>The active group receive a 6-month  physical activity program. </interventions>
    <comparator>The active and the control group receive educational material on cognitive impairment in older age and recommendations for a healthy lifestyle.</comparator>
    <control>Active</control>
    <interventioncode>None</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Cognitive decline.  </outcome>
      <timepoint>For participants with Alzheimer's disease the primary outcome will be measured 6 months after enrolment.
For participants with subjective memory complaints or mild cognitive impairment the primary outcome will be measured 18 months after enrolment.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>For participants with Alzheimer's disease the secondary outcome: quality of life.</outcome>
      <timepoint>Measured at 6 months after enrolment.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome> For participants with Mild Cognitive impairment the secondary outcome: diagnosis of dementia and quality of life.</outcome>
      <timepoint>Measured 18 months after enrolment.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Diagnosis of Mild Cognitive Impairment, subjective Memoery Complaints or mild to moderate Alzheimer's disease.</inclusivecriteria>
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>Not stated</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Clinical history of stroke, unstable or life threatening illness.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Sealed envelopes are used.</concealment>
    <sequence>Randomisation occurred in blocks. Sequence generation was performed consecutively selecting one of the identical cards from the block.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>22/04/2004</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>168</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up continuing</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Government body</primarysponsortype>
    <primarysponsorname>NHMRC</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>NHMRC</fundingname>
      <fundingaddress />
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Charities/Societies/Foundations</sponsortype>
      <sponsorname>Rotary Australia</sponsorname>
      <sponsoraddress />
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>A/Prof N Lautenschlager</name>
      <address>School of Psychiatry and Clinical Neurosciences
University of Western Australia
M 573
35 Stirling Highway
Crawley WA 6009</address>
      <phone>+61 8 92242855</phone>
      <fax />
      <email>nicolal@cyllene.uwa.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>A/Prof N Lautenschlager</name>
      <address>School of Psychiatry and Clinical Neurosciences
University of Western Australia
M 573
35 Stirling Highway
Crawley WA 6009</address>
      <phone>+61 8 92242855</phone>
      <fax />
      <email>nicolal@cyllene.uwa.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>